1233 related articles for article (PubMed ID: 21946820)
1. Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.
Blaschke F; Knaus T; Celebi O; Krebs A; Nitardy A; Habedank D; Dietz R; Stockburger M
Europace; 2012 Feb; 14(2):224-9. PubMed ID: 21946820
[TBL] [Abstract][Full Text] [Related]
2. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
[TBL] [Abstract][Full Text] [Related]
3. Dyssynchrony and the risk of ventricular arrhythmias.
Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.
Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V
Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075
[TBL] [Abstract][Full Text] [Related]
5. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
Buxton AE; Sweeney MO; Wathen MS; Josephson ME; Otterness MF; Hogan-Miller E; Stark AJ; Degroot PJ;
J Am Coll Cardiol; 2005 Jul; 46(2):310-6. PubMed ID: 16022960
[TBL] [Abstract][Full Text] [Related]
6. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
7. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH
Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022
[TBL] [Abstract][Full Text] [Related]
8. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
[TBL] [Abstract][Full Text] [Related]
9. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Zareba W; Klein H; Cygankiewicz I; Hall WJ; McNitt S; Brown M; Cannom D; Daubert JP; Eldar M; Gold MR; Goldberger JJ; Goldenberg I; Lichstein E; Pitschner H; Rashtian M; Solomon S; Viskin S; Wang P; Moss AJ;
Circulation; 2011 Mar; 123(10):1061-72. PubMed ID: 21357819
[TBL] [Abstract][Full Text] [Related]
11. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
[TBL] [Abstract][Full Text] [Related]
12. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death.
Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
[TBL] [Abstract][Full Text] [Related]
14. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
[TBL] [Abstract][Full Text] [Related]
15. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
16. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
[TBL] [Abstract][Full Text] [Related]
17. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
[TBL] [Abstract][Full Text] [Related]
18. Clustering of ventricular tachyarrhythmias in heart failure patients implanted with a biventricular cardioverter defibrillator.
Lunati M; Gasparini M; Bocchiardo M; Curnis A; Landolina M; Carboni A; Luzzi G; Zanotto G; Ravazzi P; Magenta G; Denaro A; Distefano P; Grammatico A;
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1299-306. PubMed ID: 17239095
[TBL] [Abstract][Full Text] [Related]
19. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
[TBL] [Abstract][Full Text] [Related]
20. Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
Aktas MK; Goldenberg I; Moss AJ; Huang DT; Kutyifa V; Wang PJ; Brenyo A; McNitt S; Zareba W; Barsheshet A
Am J Cardiol; 2014 Dec; 114(12):1855-60. PubMed ID: 25438913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]